Perifosine
- Generic Name
- Perifosine
- Drug Type
- Small Molecule
- Chemical Formula
- C25H52NO4P
- CAS Number
- 157716-52-4
- Unique Ingredient Identifier
- 2GWV496552
Overview
Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.
Background
Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.
Indication
Investigated for use/treatment in solid tumors, multiple myeloma, leukemia (unspecified), lung cancer, and brain cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath